当前位置: X-MOL 学术Int. J. Equity Health › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Hepatitis C drug prescriptions and Medicaid policies--four states, Indian health care system, USA 2018.
International Journal for Equity in Health ( IF 4.666 ) Pub Date : 2019-12-04 , DOI: 10.1186/s12939-019-1101-4
Brigg Reilley 1 , Matt Miller 2 , Matt Hudson 3 , Rick Haverkate 2 , Jessica Leston 1
Affiliation  

Medicaid, the state-level public insurance in the United States, has widely differing criteria treatment for hepatitis C virus (HCV) such as stage of liver fibrosis, documented sobriety, and specialist consultation. In a rural health network, facilities located in two less restrictive states prescribed HCV drugs at a significantly higher rate than two more restrictive states (rate ratio 4.7, CI 2.6-8.5). Prescription rates per population were highly associated with HCV treatment policies.

中文翻译:

丙型肝炎药物处方和医疗补助政策-四个州,印度卫生保健系统,美国,2018年。

Medicaid是美国的州级公共保险,对丙型肝炎病毒(HCV)的治疗标准差异很大,例如肝纤维化的分期,清醒的成年医生和专科医生咨询。在农村卫生网络中,位于两个限制较少的州的医疗机构开具的HCV药物的比率明显高于两个限制较大的州(比率4.7,CI 2.6-8.5)。每个人群的处方率与HCV治疗政策高度相关。
更新日期:2019-12-04
down
wechat
bug